Ascend Wellness Holdings (AAWH) Free Cash Flow (QoQ) (2020 - 2026)
Ascend Wellness Holdings (AAWH) Free Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Ascend Wellness Holdings | 77.94 Mn | 17.02 Mn | 44.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -173.88% |
| Dec 31, 2025 | 493.79% |
| Sep 30, 2025 | -193.05% |
| Jun 30, 2025 | 356.20% |
| Mar 31, 2025 | -85.13% |
| Dec 31, 2024 | 835.78% |
| Sep 30, 2024 | -95.57% |
| Jun 30, 2024 | 782.13% |
| Mar 31, 2024 | -78.52% |
| Dec 31, 2023 | -35.71% |
| Sep 30, 2023 | 28.46% |
| Jun 30, 2023 | 278.39% |
| Mar 31, 2023 | 123.61% |
| Dec 31, 2022 | -1,844.65% |
| Sep 30, 2022 | 88.44% |
| Jun 30, 2022 | 3.14% |
| Mar 31, 2022 | -129.61% |
| Dec 31, 2021 | 149.68% |
| Sep 30, 2021 | -819.39% |
| Jun 30, 2021 | 132.12% |